Login / Signup
Amivantamab: Treating EGFR Exon 20-Mutant Cancers With Bispecific Antibody-Mediated Receptor Degradation.
Jens Köhler
Pasi A Janne
Published in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Keyphrases
</>
small cell lung cancer
epidermal growth factor receptor
tyrosine kinase
wild type